The following evidence-based papers present research into various facets of Lyme disease, and are organized into three categories to expedite comprehension:

indiana lyme connect disease spacer
Treatment Guidelines

Cameron DJ, Johnson LB, Maloney EL. Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. Expert Rev Anti Infect There. 2014 Sep;12(9):1103-1135. don:10.1586/14787210.2014.940900

Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1;43(9):1089-1134.

Centers for Disease Control and Prevention (CDC). Lyme Disease (Borrelia burgdorferi) 2017 Case Definition. Council of State and Territorial Epidemiologists (CSTE) Position Statement(s)

indiana lyme connect disease spacer

Cameron DJ. Consequences of treatment delay in Lyme disease. J Eval Clin Pract. 2007 Jun;13(3):470-2.

Maloney EL. The management of Ixodes scapularis bites in the upper midwest. WMJ 2011 Apr;110(2):78-81.

Maloney EL. The need for clinical judgment in the diagnosis and treatment of Lyme diseaseJ AM Physicians Surgeons. 2009;14(3):82-89

Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department

Nigrovic LE, Bennett JE, Balamuth F, Levas MN, Chenard RL, Maulden AB, Garro AC; for Pedi Lyme Net.

Pediatrics, online first 2017 Nov 24. pii: e20171975.

Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nature Reviews Disease Primers. 2016 Dec 15;2:16090

indiana lyme connect disease spacer
Persistent Infection

Cameron DJ. Proof That Chronic Lyme Disease Exists. Interdisciplinary Perspectives on Infectious Diseases, vol. 2010 Article ID 876450, 4 pages, 2010. doi:10.1155/2010/876450

Crowder LA, Yedlin VA, Weinstein ER, Kortte KB, Aucott JN. Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyardPublic Health. 2014;128(9):784–791.

Feng J, Wang T, Shi W, et al. Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug libraryEmerging Microbes & Infections. 02 July 2014;3:e49. doi:10.1038/emi.2014.53.

Feng J, Shi W, Zhang S, Zhang Y. Persister mechanisms in Borrelia burgdorferi: implications for improved interventionEmerging Microbes & Infections. 19 August 2015;4:e51. doi:10.1038/emi.2015.51.

Johnson L, Wilcox S, Mankoff J, Stricker RB. Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey. PeerJ. 2014 Mar 27;2:e322. doi: 10.7717/peerj.322.

Lobraico J, Butler A, Petrini J, Ahmadi R. New insights into stages of Lyme disease symptoms from a novel hospital-based registry. Journal of Primary Care and Community Health. 2014;5(4):284-287.

Maloney EL. Controversies in Persistent (Chronic) Lyme Disease. J Infus Nurs. 2016 Nov; 39(6): 369–375. doi:10.1097/NAN.0000000000000195.

Rebman AW, Bechtold KT, Yang T, et al. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment Lyme disease syndromeFrontiers in Medicine (Lausanne). 2017 Dec 14;4:224.

Zhang Y. Persisters, persistent infections and the Yin–Yang modelEmerging Microbes & Infections. 2014 Jan 8;3:e3. doi:10.1038/emi.2014.3